Brief: Kingworld Medicines Expected To Record Increase In Profit Attributable By About 20% To 25% For Six Months
Aug 10 (Reuters) - Kingworld Medicines Group Ltd 1110.HK :
* EXPECTED TO RECORD INCREASE IN PROFIT ATTRIBUTABLE BY
ABOUT 20%
TO 25% FOR SIX MONTHS
* EXPECTED RESULT DUE TO SHARE OF PROFIT OF A JOINT VENTURE
BY
APPROXIMATELY 145% TO 150% FOR PERIOD, AMONG OTHERS
* SEES SHENZHEN DONG DI XIN TECHNOLOGY RECORDING DECREASE
IN
PROFIT FOR SIX MONTHS BY APPROXIMATELY 5% TO 10%
* SEES AN INCREASE IN PROFIT FOR SIX MONTHS BY
APPROXIMATELY 1%
TO 5%
* EXPECTED RESULTS OF UNIT DUE TO DROP IN SALES OF
ANTI-PANDEMIC
DEVICES
Further company coverage: 1110.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kingworld Medicines
See all newsBrief: Kingworld Medicines Group Says Unit Terminates MoU For Proposed Acquisition
Brief: Kingworld Medicines Expects To Record A Decrease In Profit Attributable By 70% To 75% For Year
Brief: Kingworld Medicines's Unit Entered Into MoU With Intended Vendor, Others
Brief: Kingworld Medicines Sees Decrease In HY Profit By 70%
Brief: Kingworld Medicines Sees Increase In Profit Attributable By 65% To 75% For Year